204 related articles for article (PubMed ID: 35563042)
1. Identification of Potential Muscle Biomarkers in McArdle Disease: Insights from Muscle Proteome Analysis.
García-Consuegra I; Asensio-Peña S; Garrido-Moraga R; Pinós T; Domínguez-González C; Santalla A; Nogales-Gadea G; Serrano-Lorenzo P; Andreu AL; Arenas J; Zugaza JL; Lucia A; Martín MA
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563042
[TBL] [Abstract][Full Text] [Related]
2. McArdle Disease: New Insights into Its Underlying Molecular Mechanisms.
Llavero F; Arrazola Sastre A; Luque Montoro M; Gálvez P; Lacerda HM; Parada LA; Zugaza JL
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775340
[TBL] [Abstract][Full Text] [Related]
3. PYGM expression analysis in white blood cells: a complementary tool for diagnosing McArdle disease?
de Luna N; Brull A; Lucia A; Santalla A; Garatachea N; Martí R; Andreu AL; Pinós T
Neuromuscul Disord; 2014 Dec; 24(12):1079-86. PubMed ID: 25240406
[TBL] [Abstract][Full Text] [Related]
4. Systemic AAV8-mediated delivery of a functional copy of muscle glycogen phosphorylase (Pygm) ameliorates disease in a murine model of McArdle disease.
McNamara EL; Taylor RL; Clayton JS; Goullee H; Dilworth KL; Pinós T; Brull A; Alexander IE; Lisowski L; Ravenscroft G; Laing NG; Nowak KJ
Hum Mol Genet; 2020 Jan; 29(1):20-30. PubMed ID: 31511858
[TBL] [Abstract][Full Text] [Related]
5. Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease.
Nogales-Gadea G; Pinós T; Lucia A; Arenas J; Camara Y; Brull A; de Luna N; Martín MA; Garcia-Arumí E; Martí R; Andreu AL
Brain; 2012 Jul; 135(Pt 7):2048-57. PubMed ID: 22730558
[TBL] [Abstract][Full Text] [Related]
6. Genes and exercise intolerance: insights from McArdle disease.
Nogales-Gadea G; Godfrey R; Santalla A; Coll-Cantí J; Pintos-Morell G; Pinós T; Arenas J; Martín MA; Lucia A
Physiol Genomics; 2016 Feb; 48(2):93-100. PubMed ID: 26465709
[TBL] [Abstract][Full Text] [Related]
7. Sodium valproate increases the brain isoform of glycogen phosphorylase: looking for a compensation mechanism in McArdle disease using a mouse primary skeletal-muscle culture in vitro.
de Luna N; Brull A; Guiu JM; Lucia A; Martin MA; Arenas J; Martí R; Andreu AL; Pinós T
Dis Model Mech; 2015 May; 8(5):467-72. PubMed ID: 25762569
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility gene card for McArdle disease.
Taylor RL; Davis M; Turner E; Brull A; Pinos T; Cabrera M; Nowak KJ
Eur J Hum Genet; 2018 May; 26(5):758-764. PubMed ID: 29371640
[TBL] [Abstract][Full Text] [Related]
9. No effect of oral ketone ester supplementation on exercise capacity in patients with McArdle disease and healthy controls: A randomized placebo-controlled cross-over study.
Løkken N; Storgaard JH; Revsbech KL; Voermans NC; Van Hall G; Vissing J; Ørngreen MC
J Inherit Metab Dis; 2022 May; 45(3):502-516. PubMed ID: 35150142
[TBL] [Abstract][Full Text] [Related]
10. Muscle molecular adaptations to endurance exercise training are conditioned by glycogen availability: a proteomics-based analysis in the McArdle mouse model.
Fiuza-Luces C; Santos-Lozano A; Llavero F; Campo R; Nogales-Gadea G; Díez-Bermejo J; Baladrón C; González-Murillo Á; Arenas J; Martín MA; Andreu AL; Pinós T; Gálvez BG; López JA; Vázquez J; Zugaza JL; Lucia A
J Physiol; 2018 Mar; 596(6):1035-1061. PubMed ID: 29315579
[TBL] [Abstract][Full Text] [Related]
11. McArdle disease: molecular genetic update.
Andreu AL; Nogales-Gadea G; Cassandrini D; Arenas J; Bruno C
Acta Myol; 2007 Jul; 26(1):53-7. PubMed ID: 17915571
[TBL] [Abstract][Full Text] [Related]
12. The effect of muscle glycogen phosphorylase (Pygm) knockdown on zebrafish morphology.
Migocka-Patrzałek M; Lewicka A; Elias M; Daczewska M
Int J Biochem Cell Biol; 2020 Jan; 118():105658. PubMed ID: 31747538
[TBL] [Abstract][Full Text] [Related]
13. Generation of the First Human In Vitro Model for McArdle Disease Based on iPSC Technology.
Ortuño-Costela MDC; Cerrada V; Moreno-Izquierdo A; García-Consuegra I; Laberthonnière C; Delourme M; Garesse R; Arenas J; Fuster García C; García García G; Millán JM; Magdinier F; Gallardo ME
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430443
[TBL] [Abstract][Full Text] [Related]
14. Phenotype consequences of myophosphorylase dysfunction: insights from the McArdle mouse model.
Brull A; de Luna N; Blanco-Grau A; Lucia A; Martin MA; Arenas J; Martí R; Andreu AL; Pinós T
J Physiol; 2015 Jun; 593(12):2693-706. PubMed ID: 25873271
[TBL] [Abstract][Full Text] [Related]
15. Missense mutations have unexpected consequences: The McArdle disease paradigm.
García-Consuegra I; Asensio-Peña S; Ballester-Lopez A; Francisco-Velilla R; Pinos T; Pintos-Morell G; Coll-Cantí J; González-Quintana A; Andreu AL; Arenas J; Lucia A; Nogales-Gadea G; Martín MA
Hum Mutat; 2018 Oct; 39(10):1338-1343. PubMed ID: 30011114
[TBL] [Abstract][Full Text] [Related]
16. [McArdle disease (gycogenosis type V): analysis of clinical, biological and genetic features of five French patients].
Delmont E; Sacconi S; Berge-Lefranc JL; Aquaron R; Butori C; Desnuelle C
Rev Neurol (Paris); 2008 Nov; 164(11):912-6. PubMed ID: 18808785
[TBL] [Abstract][Full Text] [Related]
17. Muscle Glycogen Phosphorylase and Its Functional Partners in Health and Disease.
Migocka-Patrzałek M; Elias M
Cells; 2021 Apr; 10(4):. PubMed ID: 33924466
[TBL] [Abstract][Full Text] [Related]
18. McArdle disease in a patient with anorexia nervosa: a case report.
Dalle Grave R; Patacca E; Conti M; Soave F; Dametti L; Dalle Grave A; Calugi S
Eat Weight Disord; 2022 Dec; 27(8):3793-3796. PubMed ID: 35871462
[TBL] [Abstract][Full Text] [Related]
19. Differential Muscle Involvement in Mice and Humans Affected by McArdle Disease.
Krag TO; Pinós T; Nielsen TL; Brull A; Andreu AL; Vissing J
J Neuropathol Exp Neurol; 2016 May; 75(5):441-54. PubMed ID: 27030740
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
